(Q43040005)

English

Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Shigenobu Kawai

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Osamu Yokosuka

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fumio Imazeki

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hiromitsu Saisho

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chitose Mizuno

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

343-351

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Performance of an automated system for quantification of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Quantitative measurement of HCV RNA in the serum: a comparison of three assays based on different principles

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Implications of variations of "conserved" regions of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

A second group of hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

A novel method employing UNG to avoid carry-over contamination in RNA-PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.10209

21 January 2018

Identifiers

10.1002/JMV.10209

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43040005&oldid=2099858647"